Adverse health effects of environmental chemical agents through non-genotoxic mechanisms

Journal of Epidemiology and Community Health

Volumn 65, Issue 1, 2011, Pages 1-3

  Henkler, Frank ^a   Luch, Andreas ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; ENDOCRINE DISRUPTOR; XENOBIOTIC AGENT;

CHEMICAL COMPOUND; DISEASE PREVALENCE; DISEASE SEVERITY; EPIDEMIOLOGY; GENOTOXICITY; HEALTH RISK; OCCUPATIONAL EXPOSURE; POLLUTION EFFECT; PUBLIC HEALTH;

APOPTOSIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; HUMAN; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION;

APOPTOSIS; CARCINOGENS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL EXPOSURE; HUMANS; NEOPLASMS; SIGNAL TRANSDUCTION; XENOBIOTICS;

EID: 78650923948     PISSN: 0143005X     EISSN: 14702738     Source Type: Journal    
DOI: 10.1136/jech.2008.083881     Document Type: Review

References (16)

1. Gronemeyer H, Gustafsson JA, Laudet V. Principles for modulation of the nuclear receptor superfamily. Nat Rev Drug Discov 2004;3:950-64.
2. Puga A, Ma C, Marlowe JL. The aryl hydrocarbon receptor cross-talks with multiple signal transduction pathways. Biochem Pharmacol 2009;77:713-22.
3. Luch A. The mode of action of organic carcinogens on cellular structures. EXS 2006;96:65-95.
4. SCTEE. Human and wildlife health effects of endocrine disrupting chemicals with emphasis on wildlife on ecotoxicology test methods. European Commission Scientific Committee for Toxicity, Ecotoxicity and the Environment (SCTEE). Brussels, Belgium, 1999.
5. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, et al. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev2009;30:293-342.
6. EPA. Research plan for endocrine disruptors. United States Environmental Protection Agency (EPA). Research Triangle Park, NC, USA, 1998.
7. COM. 706. Community Strategy for Endocrine DisruptersdA range of substances suspected of interfering with the hormone systems of humans and wildlife. 1999. [http://ec.europa.eu/environment/endocrine/documents/comm1999- en.htm]. (accessed 1 May 2010).
8. Halliwell S, Gutteridge JMC. Free radicals in biology and medicine. 4th edn. New York: Oxford University Press, 2007.
9. Gloire G, Legrand-Poels S, Piette J. NF-kB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol 2006;72:1493-505.
10. Schrader M, Fahimi HD. Peroxisomes and oxidative stress. Biochim Biophys Acta 2006;1763:1755-66.
11. Pilger A, Rudiger HW.8-Hydroxy-29-deoxyguanosine as a marker of oxidative DNA damage related to occupational and environmental exposure. Int Arch Occup Environ Health 2006;80:1-15.
12. Henkler F, Brinkmann J, Luch A. The role of oxidative stress in carcinogenesis induced by metals and xenobiotics. Cancers 2010;2:376-96.
13. Loeb LA. A mutator phenotype in cancer. Cancer Res 2001;61:3230-9.
14. Gerl R, Vaux DL. Apoptosis in the development and treatment of cancer. Carcinogenesis 2005;26:263-70.
15. Pommier Y, Sordet O, Antony S, et al. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 2004;23:2924-49.
16. Tian Y. Ah receptor and NF-kB interplay on the stage of epigenome. Biochem Pharmacol 2009;77:670-80.